EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Newsroom
Company News
Media Report
Company News
More
2024-06-25
CanSinoBIO Executives Talk with WHO Experts on the Development Progress of Polio Vaccines
CanSinoBIO Announces Priority Review Status for DTcP Infant
2025-02-07
CanSinoBIO Obtained Halal Decree of Menhycia® in Indonesia
2025-02-06
CanSinoBIO Received Acceptance of New Drug Application for its Tetanus Vaccine
2025-02-06
CanSinoBIO Secures Further Grant Funding
2024-10-09
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine
2024-04-26
Media Report
More
CanSinoBIO Secures Further Funding from the Bill & Melinda Gates Foundation
Time：2024-10-09
Source：ACN Newswire
More
CanSinoBIO Reports Outstanding H1 2024 Performance
Time：2024-08-29
Source：ACN Newswire
More
Pharma Boardroom: Yu Xuefeng – CEO & Chairman, CanSinoBIO
Time：2024-07-26
Source：Pharma Boardroom
More
津公网安备12011602300399
